Brigitte Schürch

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


144 publications

2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1991 | 1990 | 1988 | 1987 | 1980 |
 
Alpha-blockers for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
Schneider M.P., Tornic J., Sýkora R., Abo Youssef N., Mordasini L., Krhut J., Chartier-Kastler E., Davies M., Gajewski J., Schurch B. et al., 2019/08. Neurourology and urodynamics, 38 (6) pp. 1482-1491. Peer-reviewed.
 
Botulinum Toxin Type A Injection After Failure of Augmentation Enterocystoplasty Performed for Neurogenic Detrusor Overactivity: Preliminary Results of a Salvage Strategy. The ENTEROTOX Study.
Michel F., Ciceron C., Bernuz B., Boissier R., Gaillet S., Even A., Chartier-Kastler E., Denys P., Gamé X., Ruffion A. et al., 2019/07. Urology, 129 pp. 43-47. Peer-reviewed.
 
Indications à un bilan urodynamique et à une antibioprophylaxie avant celui-ci [About the indications to urodynamic studies and to a prior antibioprophylaxy]
Micol L.A., Rakauskas A., Schurch B., 2018/11/28. Revue medicale suisse, 14 (629) pp. 2167-2171. Peer-reviewed.
 
Targeted neurotechnology restores walking in humans with spinal cord injury.
Wagner F.B., Mignardot J.B., Le Goff-Mignardot C.G., Demesmaeker R., Komi S., Capogrosso M., Rowald A., Seáñez I., Caban M., Pirondini E. et al., 2018/11. Nature, 563 (7729) pp. 65-71. Peer-reviewed.
 
Intradetrusor Injections of Botulinum Toxin A in Adults with Spinal Dysraphism.
Peyronnet B., Even A., Capon G., De Seze M., Hascoet J., Biardeau X., Baron M., Perrouin-Verbe M.A., Boutin J.M., Saussine C. et al., 2018/10. The Journal of urology, 200 (4) pp. 875-880. Peer-reviewed.
 
Screening for urinary incontinence in acute care for elders unit: comparative performance analysis of Katz's ADL and ICIQ-UI-SF
Mary-Heck G., Krief H., Akrour R., Ishida M., Schurch B., Lang P.-O., 2018/10. European Geriatric Medicine, 9 (5) pp. 579-588. Peer-reviewed.
 
What is the exact working mechanism of botulinum toxin A and sacral nerve stimulation in the treatment of overactive bladder/detrusor overactivity? ICI-RS 2017.
Malde S., Fry C., Schurch B., Marcelissen T., Averbeck M., Digesu A., Sahai A., 2018/06. Neurourology and urodynamics, 37 (S4) pp. S108-S116. Peer-reviewed.
 
Conditional neuromodulation of neurogenic detrusor overactivity using transrectal stimulation in patients with spinal cord injury: A proof of principle study. Knight SL, Edirisinghe N, Leaker B, Susser J, Craggs MD, Neurourol Urodyn. 2017 Jun 30.
Schurch B., Karsenty G., 2018/04. Neurourology and urodynamics, 37 (4) pp. 1507-1508. Peer-reviewed.
 
An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD).
Gajewski J.B., Schurch B., Hamid R., Averbeck M., Sakakibara R., Agrò E.F., Dickinson T., Payne C.K., Drake M.J., Haylen B.T., 2018/03. Neurourology and urodynamics, 37 (3) pp. 1152-1161. Peer-reviewed.
 
Long-term outcomes and risks factors for failure of intradetrusor onabotulinumtoxin A injections for the treatment of refractory neurogenic detrusor overactivity.
Joussain C., Popoff M., Phé V., Even A., Bosset P.O., Pottier S., Falcou L., Levy J., Vaugier I., Chartier Kastler E. et al., 2018/02. Neurourology and urodynamics, 37 (2) pp. 799-806. Peer-reviewed.
 
Urodynamics in patients with spinal cord injury: A clinical review and best practice paper by a working group of The International Continence Society Urodynamics Committee.
Schurch B., Iacovelli V., Averbeck M.A., Stefano C., Altaweel W., Finazzi Agrò E., 2018/02. Neurourology and urodynamics, 37 (2) pp. 581-591. Peer-reviewed.
 
The efficacy of botulinum toxin A and sacral neuromodulation in the management of interstitial cystitis (IC)/bladder pain syndrome (BPS), what do we know? ICI-RS 2017 think thank, Bristol.
Rahnama'i M.S., Marcelissen T., Apostolidis A., Veit-Rubin N., Schurch B., Cardozo L., Dmochowski R., 2018/01/24. Neurourology and urodynamics, 37 pp. S99-S107. Peer-reviewed.
 
Nycturie du patient âgé : en pratique [Nocturia in aged patient: in practice]
Da Costa A., Ishida M., Akrour R., Mary-Heck G., Grilo N., Schurch B., Lang P.O., 2017/11/08. Revue medicale suisse, 13 (582) pp. 1946-1951. Peer-reviewed.
 
Long-term compliance and results of intravesical botulinum toxin A injections in male patients.
Rahnama'i M.S., Marcelissen TAT, Brierley B., Schurch B., de Vries P., 2017/09. Neurourology and urodynamics, 36 (7) pp. 1855-1859. Peer-reviewed.
 
A multidirectional gravity-assist algorithm that enhances locomotor control in patients with stroke or spinal cord injury.
Mignardot J.B., Le Goff C.G., van den Brand R., Capogrosso M., Fumeaux N., Vallery H., Anil S., Lanini J., Fodor I., Eberle G. et al., 2017/07/19. Science translational medicine, 9 (399) pp. eaah3621. Peer-reviewed.
 
Long-term follow-up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms.
Marcelissen T.A., Rahnama'i M.S., Snijkers A., Schurch B., De Vries P., 2017/02. World journal of urology, 35 (2) pp. 307-311. Peer-reviewed.
 
Injections intra-détrusoriennes de toxine botulique chez l'adulte spina bifida : résultats d'une étude multicentrique
Peyronnet B., Even A., Verrando A., Capon G., De Seze M., Hascoet J., Lenormand C., Maurin C., Biardeau X., Monleon L. et al., 2016/11., Association française d'urologie pp. 721-722 dans 110e Congrès français d'urologie, Progrès en Urologie.
 
Peut-on éviter l'entérocystoplastie d'agrandissement en cas d'échec d'une première injection intra-détrusorienne de toxine botulique chez un patient spina bifida ?
Peyronnet B., Amarenco G., De seze M., Schurch B., Even A., Capon G., Baron M., Hascoet J., Castel-lacanal E., Lenormand C. et al., 2016/11., Société française d'urologie pp. 722-723 dans 110e Congrès français d'urologie, Progrès en Urologie.
 
Long-term real life efficacy of onabotulinum toxin A for the treatment of neurogenic detrusor overactivity in a population using intermittent self-catheterization.
Joussain C., Popoff M., Phé V., Even A., Falcou L., Chartier-Kastler E., Schurch B., Denys P., 2016. Annals of Physical and Rehabilitation Medicine, 59S pp. e105. Peer-reviewed.
 
Dysfunction of lower urinary tract in patients with spinal cord injury.
Schurch B., Tawadros C., Carda S., 2015. Handbook of Clinical Neurology, 130 pp. 247-267. Peer-reviewed.
 
Définition et prise en charge de l'échec d'une première injection de toxine botulique Botox ® 200 U pour hyperactivité détrusorienne neurogène: résultats de l'enquête DETOX [Definition of botulinum toxin failure in neurogenic detrusor overactivity: Preliminary results of the DETOX survey].
Peyronnet B., Sanson S., Amarenco G., Castel-Lacanal E., Chartier-Kastler E., Charvier K., Damphousse M., Denys P., de Seze M., Egon G. et al., 2015. Progrès En Urologie, 25 (17) pp. 1219-1224. Peer-reviewed.
 
Neuroprosthetic technologies to augment the impact of neurorehabilitation after spinal cord injury.
van den Brand R., Mignardot J.B., von Zitzewitz J., Le Goff C., Fumeaux N., Wagner F., Capogrosso M., Martin Moraud E., Micera S., Schurch B. et al., 2015. Annals of Physical and Rehabilitation Medicine, 58 (4) pp. 232-237. Peer-reviewed.
Supraspinal Control of Urine Storage and Micturition in Men--An fMRI Study.
Michels L., Blok B.F., Gregorini F., Kurz M., Schurch B., Kessler T.M., Kollias S., Mehnert U., 2015. Cerebral Cortex, 25 (10) pp. 3369-3380. Peer-reviewed.
OnabotulinumtoxinA and multiple sclerosis.
Schurch B., Carda S., 2014. Annals of Physical and Rehabilitation Medicine, 57 (5) pp. 302-314. Peer-reviewed.
 
Intérêt d'une Consultation spécialisée multidisciplinaire en neuro-urologie et urologie fonctionnelle [Benefit of a specialized multidisciplinary clinic in neuro-urology and functional urology].
Tawadros C., Tawadros T., Julita L., Jichlinski P., Schurch B., 2013. Revue Médicale Suisse, 9 (409) pp. 2286-2288.
 
The supraspinal neural correlate of bladder cold sensation--an fMRI study.
Mehnert U., Michels L., Zempleni M.Z., Schurch B., Kollias S., 2011. Human Brain Mapping, 32 (6) pp. 835-845.
 
Cortical substrate of bladder control in SCI and the effect of peripheral pudendal stimulation.
Zempleni M.Z., Michels L., Mehnert U., Schurch B., Kollias S., 2010. Neuroimage, 49 (4) pp. 2983-2994.
 
Neurologic fecal incontinence.
Wyndaele J.J., Kovindha A., Igawa Y., Madersbacher H., Radziszewski P., Ruffion A., Schurch B., Castro D., Sakakibara R., Wein A. et al., 2010. Neurourology and Urodynamics, 29 (1) pp. 207-212.
 
Neurologic urinary incontinence.
Wyndaele J.J., Kovindha A., Madersbacher H., Radziszewski P., Ruffion A., Schurch B., Castro D., Igawa Y., Sakakibara R., Wein A. et al., 2010. Neurourology and Urodynamics, 29 (1) pp. 159-164.
 
New strategies of pelvic nerves stimulation for recovery of pelvic visceral functions and locomotion in paraplegics.
Possover M., Schurch B., Henle K.P., 2010. Neurourology and Urodynamics, 29 (8) pp. 1433-1438.
 
Proof of principle: The effect of antimuscarinics on bladder filling sensations in healthy subjects--a placebo controlled double blind investigation using 4 and 8 mg tolterodine extended release.
Mehnert U., Reitz A., Youssef S.A., Schurch B., 2010. Neurourology and Urodynamics, 29 (3) pp. 464-469.
 
Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis.
Kessler T.M., La Framboise D., Trelle S., Fowler C.J., Kiss G., Pannek J., Schurch B., Sievert K.D., Engeler D.S., 2010. European Urology, 58 (6) pp. 865-874.
 
The effect of botulinum toxin type a on overactive bladder symptoms in patients with multiple sclerosis: a pilot study.
Mehnert U., Birzele J., Reuter K., Schurch B., 2010. Journal of Urology, 184 (3) pp. 1011-1016.
 
The effect of tolterodine 4 and 8 mg on the heart rate variability in healthy subjects.
Schiffers M., Sauermann P., Schurch B., Mehnert U., 2010. World Journal of Urology, 28 (5) pp. 651-656.
 
The somatosensory representation of the human clitoris: an fMRI study.
Michels L., Mehnert U., Boy S., Schurch B., Kollias S., 2010. Neuroimage, 49 (1) pp. 177-184.
 
What treatment should we use if drugs fail for OAB; and, what really works after drugs?
Bosch J.L., Kelleher C., van Kerrebroeck P.E., Schurch B., 2010. Neurourology and Urodynamics, 29 (4) pp. 658-661.
 
A morphological evaluation of botulinum neurotoxin A injections into the detrusor muscle using magnetic resonance imaging.
Mehnert U., Boy S., Schmid M., Reitz A., von Hessling A., Hodler J., Schurch B., 2009. World Journal of Urology, 27 (3) pp. 397-403.
 
Botulinumtoxin bei nichtneurogenen Blasenfunktionsstörungen [Botulinum toxin in nonneurogenic bladder dysfunction].
Mehnert U., Schurch B., 2009. Urologe. Ausgabe A, 48 (3) pp. 233-244.
 
Editorial comment on: Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
Schurch B., 2009. European Urology, 55 (3) pp. 711-712.
 
Heart rate variability: an objective measure of autonomic activity and bladder sensations during urodynamics.
Mehnert U., Knapp P.A., Mueller N., Reitz A., Schurch B., 2009. Neurourology and Urodynamics, 28 (4) pp. 313-319.
 
International standards to document remaining autonomic function after spinal cord injury.
Alexander M.S., Biering-Sorensen F., Bodner D., Brackett N.L., Cardenas D., Charlifue S., Creasey G., Dietz V., Ditunno J., Donovan W. et al., 2009. Spinal Cord, 47 (1) pp. 36-43.
 
Outcome measures in spinal cord injury: recent assessments and recommendations for future directions.
Alexander M.S., Anderson K.D., Biering-Sorensen F., Blight A.R., Brannon R., Bryce T.N., Creasey G., Catz A., Curt A., Donovan W. et al., 2009. Spinal Cord, 47 (8) pp. 582-591.
 
Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report.
Apostolidis A., Dasgupta P., Denys P., Elneil S., Fowler C.J., Giannantoni A., Karsenty G., Schulte-Baukloh H., Schurch B., Wyndaele J.J. et al., 2009. European Urology, 55 (1) pp. 100-119.
 
The facilitatory effect of duloxetine combined with pelvic floor muscle training on the excitability of urethral sphincter motor neurons.
Mehnert U., Boy S., Widmer-Simitovic S., Reitz A., Schurch B., 2009. International Urogynecology Journal and Pelvic Floor Dysfunction, 20 (6) pp. 659-666.
 
Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Naumann M., So Y., Argoff C.E., Childers M.K., Dykstra D.D., Gronseth G.S., Jabbari B., Kaufmann H.C., Schurch B., Silberstein S.D. et al., 2008. Neurology, 70 (19) pp. 1707-1714.
 
Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.
Karsenty G., Denys P., Amarenco G., De Seze M., Gamé X., Haab F., Kerdraon J., Perrouin-Verbe B., Ruffion A., Saussine C. et al., 2008. European Urology, 53 (2) pp. 275-287.
 
Brain activation in response to bladder filling and simultaneous stimulation of the dorsal clitoral nerve--an fMRI study in healthy women.
Mehnert U., Boy S., Svensson J., Michels L., Reitz A., Candia V., Kleiser R., Kollias S., Schurch B., 2008. Neuroimage, 41 (3) pp. 682-689.
 
Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence.
Schurch B., Denys P., Kozma C.M., Reese P.R., Slaton T., Barron R.L., 2007. European Urology, 52 (3) pp. 850-858.
 
Can the ice-water test predict the outcome of intradetrusor injections of botulinum toxin in patients with neurogenic bladder dysfunction?
Huwyler M., Schurch B., Knapp P.A., Reitz A., 2007. World Journal of Urology, 25 (6) pp. 613-617.
 
Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity.
Reitz A., Denys P., Fermanian C., Schurch B., Comperat E., Chartier-Kastler E., 2007. European Urology, 52 (6) pp. 1729-1735.
 
Does tolterodine extended release affect the bladder electrical perception threshold? A placebo controlled, double-blind study with 4 and 8 mg in healthy volunteers.
Mehnert U., Reitz A., Ziegler M., Knapp P.A., Schurch B., 2007. Journal of Urology, 178 (6) pp. 2495-2500.
 
Lebensqualität bei deutschsprachigen Patienten mit Rückenmarkverletzungen und Blasenfunktionsstörungen. Validierung der deutschen Adaption des Qualiveen-Fragebogens [Quality of life in German-speaking patients with spinal cord injuries and bladder dysfunctions. Validation of the German version of the Qualiveen questionnaire].
Pannek J., Märk R., Stöhrer M., Schurch B., 2007. Urologe. Ausgabe A, 46 (10) pp. 1416-1421.
 
Reliability and validity of the Incontinence Quality of Life questionnaire in patients with neurogenic urinary incontinence.
Schurch B., Denys P., Kozma C.M., Reese P.R., Slaton T., Barron R., 2007. Archives of Physical Medicine and Rehabilitation, 88 (5) pp. 646-652.
 
Sacral neuromodulation for refractory lower urinary tract dysfunction: results of a nationwide registry in Switzerland.
Kessler T.M., Buchser E., Meyer S., Engeler D.S., Al-Khodairy A.W., Bersch U., Iselin C.E., Roche B., Schmid D.M., Schurch B. et al., 2007. European Urology, 51 (5) pp. 1357-1363.
 
The effects of tolterodine on bladder-filling sensations and perception thresholds to intravesical electrical stimulation: method and initial results.
Boy S., Schurch B., Mehnert U., Mehring G., Karsenty G., Reitz A., 2007. BJU International, 100 (3) pp. 574-578.
 
Traitement pharmacologique de l'hyperactivité détrusorienne neurologique: injections intra-détrusoriennes de toxine botulique A [Pharmacological treatment of neurogenic detrusor hyperactivity: intradetrusor botulinum toxin A injections].
Karsenty G., Corcos J., Schurch B., Ruffion A., Chartier-Kastler E., 2007. Progrès en Urologie, 17 (3) pp. 568-575.
 
Botulinum toxin for the management of bladder dysfunction.
Schurch B., 2006. Drugs, 66 (10) pp. 1301-1318.
 
Distribution of neuropeptide Y-containing nerves in the neurogenic and non-neurogenic detrusor.
Haferkamp A., Freund T., Wagener N., Reitz A., Schurch B., Doersam J., Schumacher S., Bastian P.J., Buettner R.J., Mueller S.C. et al., 2006. BJU International, 97 (2) pp. 393-399.
 
Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
Schmid D.M., Sauermann P., Werner M., Schuessler B., Blick N., Muentener M., Strebel R.T., Perucchini D., Scheiner D., Schaer G. et al., 2006. Journal of Urology, 176 (1) pp. 177-185.
 
Facilitatory neuromodulative effect of duloxetine on pudendal motor neurons controlling the urethral pressure: a functional urodynamic study in healthy women.
Boy S., Reitz A., Wirth B., Knapp P.A., Braun P.M., Haferkamp A., Schurch B., 2006. European Urology, 50 (1) pp. 119-125.
 
Improving the global management of the neurogenic bladder patient: part I. The complexity of patients.
Denys P., Corcos J., Everaert K., Chartier-Kastler E., Fowler C., Kalsi V., Nitti V., Schulte-Baukloh H., Schurch B., 2006. Current Medical Research and Opinion, 22 (2) pp. 359-365.
 
Improving the global management of the neurogenic bladder patient: part II. Future treatment strategies.
Denys P., Corcos J., Everaert K., Chartier-Kastler E., Fowler C., Kalsi V., Nitti V., Schulte-Baukloh H., Schurch B., 2006. Current Medical Research and Opinion, 22 (5) pp. 851-860.
 
Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity.
Karsenty G., Reitz A., Lindemann G., Boy S., Schurch B., 2006. Urology, 68 (6) pp. 1193-1197.
 
Systemic augmentation of nitric oxide: is there an immediate effect on the urinary flow rate in healthy men?
Müntener M., Reitz A., Wefer B., Schurch B., 2006. Urologia Internationalis, 76 (1) pp. 31-35.
 
Systemic nitric oxide augmentation leads to a rapid decrease of the bladder outlet resistance in healthy men.
Müntener M., Schurch B., Wefer B., Reitz A., 2006. European Urology, 50 (1) pp. 112-117; discussion 117-118.
 
Toxines botuliques: applications urologiques [Urological applications of botulinum toxins].
Karsenty G., Corcos J., Schurch B., 2006. Progrès en Urologie, 16 (3) pp. 263-274.
 
A case of undiagnosed tethered cord syndrome aggravated by transurethral prostate resection.
Boy S., Reitz A., Curt A., Schurch B., 2005. Nature Clinical Practice. Urology, 2 (4) pp. 199-204; quiz 1 p following 204.
 
An fMRI study of the role of suprapontine brain structures in the voluntary voiding control induced by pelvic floor contraction.
Zhang H., Reitz A., Kollias S., Summers P., Curt A., Schurch B., 2005. Neuroimage, 24 (1) pp. 174-180.
 
Botulinum toxin injections for paediatric incontinence.
Schurch B., Corcos J., 2005. Current Opinion in Urology, 15 (4) pp. 264-267.
 
Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
Schurch B., de Sèze M., Denys P., Chartier-Kastler E., Haab F., Everaert K., Plante P., Perrouin-Verbe B., Kumar C., Fraczek S. et al., 2005. Journal of Urology, 174 (1) pp. 196-200.
 
Can neurologic examination predict type of detrusor sphincter-dyssynergia in patients with spinal cord injury?
Schurch B., Schmid D.M., Karsenty G., Reitz A., 2005. Urology, 65 (2) pp. 243-246.
 
Conditioning stimulus can influence an external urethral sphincter contraction evoked by a magnetic stimulation.
Wefer B., Reitz A., Knapp P.A., Bannowsky A., Juenemann K.P., Schurch B., 2005. Neurourology and Urodynamics, 24 (4) pp. 311-317; discussion 318.
 
Motor evoked potentials (MEP) and evoked pressure curves (EPC) from the urethral compressive musculature (UCM) by functional magnetic stimulation in healthy volunteers and patients with neurogenic incontinence.
Schmid D.M., Curt A., Hauri D., Schurch B., 2005. Neurourology and Urodynamics, 24 (2) pp. 117-127.
 
Recurrent vesical calculi, hypercalciuria, and biochemical evidence of increased bone resorption in an adult male with paraplegia due to spinal cord injury: is there a role for intermittent oral disodium etidronate therapy for prevention of calcium phosphate bladder stones?
Vaidyanathan S., Watson I.D., Jonsson O., Buczynski A.Z., Grases F., Heilberg I.P., Yasui T., Wyndaele J.J., Tozawa K., Kohri K. et al., 2005. Spinal Cord, 43 (5) pp. 269-277.
 
Sleep-related painful erections.
Karsenty G., Werth E., Knapp P.A., Curt A., Schurch B., Bassetti C.L., 2005. Nature Clinical Practice. Urology, 2 (5) pp. 256-260; quiz 261.
 
Targeting bladder outlet obstruction from benign prostatic enlargement via the nitric oxide/cGMP pathway?
Reitz A., Müntener M., Haferkamp A., Hohenfellner M., Schurch B., 2005. BJU International, 96 (3) pp. 250-253.
 
Understanding detrusor sphincter dyssynergia--significance of chronology.
Karsenty G., Reitz A., Wefer B., Boy S., Schurch B., 2005. Urology, 66 (4) pp. 763-768.
 
Apomorphine sublingual as primary or secondary treatment for erectile dysfunction in patients with spinal cord injury.
Strebel R.T., Reitz A., Tenti G., Curt A., Hauri D., Schurch B., 2004. BJU International, 93 (1) pp. 100-104.
 
Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity.
Reitz A., Schurch B., 2004. Journal of Urology, 171 (2 Pt 1) pp. 804; discussion 804-804; discussion 805.
 
Botulinumtoxin in der Urologie. Indikationen und Ergebnisse [Botulinum toxin in urology. Indications and results].
Schurch B., Reitz A., 2004. Urologe. Ausgabe A, 43 (11) pp. 1410-1415.
 
Die Auswirkungen einer Rückenmarkverletzung auf Sexualität und Reproduktion [The impact of spinal cord injury on sexuality and reproduction].
Reitz A., Burgdörfer H., Schurch B., 2004. Urologe. Ausgabe A, 43 (1) pp. 52-63.
 
Electromotive drug administration of lidocaine to anesthetize the bladder before botulinum-A toxin injections into the detrusor.
Schurch B., Reitz A., Tenti G., 2004. Spinal Cord, 42 (6) pp. 338-341.
 
European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity.
Reitz A., Stöhrer M., Kramer G., Del Popolo G., Chartier-Kastler E., Pannek J., Burgdörfer H., Göcking K., Madersbacher H., Schumacher S. et al., 2004. European Urology, 45 (4) pp. 510-515.
 
Functional magnetic stimulation of the spinal cord--a urodynamic study in healthy humans.
Reitz A., Knapp P.A., Frey S., Schurch B., 2004. Neurourology and Urodynamics, 23 (2) pp. 148-153.
 
Impact of spinal cord injury on sexual health and quality of life.
Reitz A., Tobe V., Knapp P.A., Schurch B., 2004. International Journal of Impotence Research, 16 (2) pp. 167-174.
 
Increased expression of connexin 43 in the overactive neurogenic detrusor.
Haferkamp A., Mundhenk J., Bastian P.J., Reitz A., Dörsam J., Pannek J., Schumacher S., Schurch B., Büttner R., Müller S.C., 2004. European Urology, 46 (6) pp. 799-805.
 
Intravesical therapy options for neurogenic detrusor overactivity.
Reitz A., Schurch B., 2004. Spinal Cord, 42 (5) pp. 267-272.
 
Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder.
Haferkamp A., Schurch B., Reitz A., Krengel U., Grosse J., Kramer G., Schumacher S., Bastian P.J., Büttner R., Müller S.C. et al., 2004. European Urology, 46 (6) pp. 784-791.
 
Nocturnal penile tumescence and rigidity (NPTR) findings in spinal cord injured men with erectile dysfunction.
Schmid D.M., Hauri D., Schurch B., 2004. International Journal of Impotence Research, 16 (5) pp. 433-440.
 
Oral nitric oxide donors: a new pharmacological approach to detrusor-sphincter dyssynergia in spinal cord injured patients?
Reitz A., Knapp P.A., Müntener M., Schurch B., 2004. European Urology, 45 (4) pp. 516-520.
 
The effect of nitric oxide on the resting tone and the contractile behaviour of the external urethral sphincter: a functional urodynamic study in healthy humans.
Reitz A., Bretscher S., Knapp P.A., Müntener M., Wefer B., Schurch B., 2004. European Urology, 45 (3) pp. 367-373.
 
The effect of tamsulosin on the resting tone and the contractile behaviour of the female urethra: a functional urodynamic study in healthy women.
Reitz A., Haferkamp A., Kyburz T., Knapp P.A., Wefer B., Schurch B., 2004. European Urology, 46 (2) pp. 235-240; discussion 240.
 
The role of botulinum toxin in neurourology.
Schurch B., 2004. Drugs of Today, 40 (3) pp. 205-212.
 
Urethral evoked sympathetic skin responses and viscerosensory evoked potentials as diagnostic tools to evaluate urogenital autonomic afferent innervation in spinal cord injured patients.
Schmid D.M., Reitz A., Curt A., Hauri D., Schurch B., 2004. Journal of Urology, 171 (3) pp. 1156-1160.
 
Afferent fibers of the pudendal nerve modulate sympathetic neurons controlling the bladder neck.
Reitz A., Schmid D.M., Curt A., Knapp P.A., Schurch B., 2003. Neurourology and Urodynamics, 22 (6) pp. 597-601.
 
Autonomic dysreflexia in response to pudendal nerve stimulation.
Reitz A., Schmid D.M., Curt A., Knapp P.A., Schurch B., 2003. Spinal Cord, 41 (10) pp. 539-542.
 
Botulinum toxin as a new therapy option for voiding disorders: current state of the art.
Leippold T., Reitz A., Schurch B., 2003. European Urology, 44 (2) pp. 165-174.
 
Clinical value of combined electrophysiological and urodynamic recordings to assess sexual disorders in spinal cord injured men.
Schmid D.M., Curt A., Hauri D., Schurch B., 2003. Neurourology and Urodynamics, 22 (4) pp. 314-321.
 
Electrophysiological assessment of sensations arising from the bladder: are there objective criteria for subjective perceptions?
Reitz A., Schmid D.M., Curt A., Knapp P.A., Jensen K., Schurch B., 2003. Journal of Urology, 169 (1) pp. 190-194.
 
Electrophysiological recordings during the peripheral nerve evaluation (PNE) test in complete spinal cord injury patients.
Schurch B., Reilly I., Reitz A., Curt A., 2003. World Journal of Urology, 20 (6) pp. 319-322.
 
Organisation of the sympathetic skin response in spinal cord injury.
Reitz A., Curt A., Schurch B., 2003. Journal of Neurology, Neurosurgery, and Psychiatry, 74 (7) p. 1008.
 
Value of sensory examination in predicting bladder function in patients with T12-L1 fractures and spinal cord injury.
Schurch B., Schmid D.M., Kaegi K., 2003. Archives of Physical Medicine and Rehabilitation, 84 (1) pp. 83-89.
 
Magnetic stimulation of sacral roots for assessing the efferent neuronal pathways of lower urinary tract.
Rodic B., Schläpfer A., Curt A., Knapp P., Dietz V., Schurch B., 2002. Muscle and Nerve, 26 (4) pp. 486-491.
 
Persistent paraplegia after an aqueous 7.5% phenol solution to the anterior motor root for intercostal neurolysis: a case report.
Kowalewski R., Schurch B., Hodler J., Borgeat A., 2002. Archives of Physical Medicine and Rehabilitation, 83 (2) pp. 283-285.
 
Sympathetic sudomotor skin activity in human after complete spinal cord injury.
Reitz A., Schmid D.M., Curt A., Knapp P.A., Schurch B., 2002. Autonomic Neuroscience, 102 (1-2) pp. 78-84.
 
Buttock placement of the implantable pulse generator: a new implantation technique for sacral neuromodulation--a multicenter study.
Scheepens W.A., Weil E.H., van Koeveringe G.A., Rohrmann D., Hedlund H.E., Schurch B., Ostardo E., Pastorello M., Ratto C., Nordling J. et al., 2001. European Urology, 40 (4) pp. 434-438.
 
Transient paralysis of the bladder due to wound botulism.
Sautter T., Herzog A., Hauri D., Schurch B., 2001. European Urology, 39 (5) pp. 610-612.
 
Bladder neck incompetence in patients with spinal cord injury: significance of sympathetic skin response.
Rodic B., Curt A., Dietz V., Schurch B., 2000. Journal of Urology, 163 (4) pp. 1223-1227.
 
Blasendysfunktion nach spinalen und peripheren Nervenläsionen [Bladder dysfunction after spinal and peripheral nerve lesions].
Schürch B., 2000. Therapeutische Umschau. Revue Thérapeutique, 57 (11) pp. 690-697.
 
Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.
Schurch B., Stöhrer M., Kramer G., Schmid D.M., Gaul G., Hauri D., 2000. Journal of Urology, 164 (3 Pt 1) pp. 692-697.
 
Neurogene Blasenfunktionsstörungen. Aktueller Stand der Diagnostik und Therapie [Neurogenic voiding disorders. Current status of diagnosis and therapy].
Schürch B., 2000. Schweizerische Medizinische Wochenschrift, 130 (43) pp. 1618-1626.
 
Report of the IDECG Working Group on body weight and body composition of the elderly.
Ferro-Luzzi A., Toth M.J., Elia M., Schürch B., International Dietary Energy Consultative Group, 2000. European Journal of Clinical Nutrition, 54 (Suppl. 3) pp. S160-S161.
 
Sildenafil in the treatment of sexual dysfunction in spinal cord-injured male patients.
Schmid D.M., Schurch B., Hauri D., 2000. European Urology, 38 (2) pp. 184-193.
 
Treatment of neurogenic incontinence with botulinum toxin A.
Schurch B., Schmid D.M., Stöhrer M., 2000. New England Journal of Medicine, 342 (9) p. 665.
 
Intraurethral sphincter prosthesis to treat hyporeflexic bladders in women: does it work?
Schurch B., Suter S., Dubs M., 1999. BJU International, 84 (7) pp. 789-794.
 
Report of the IDECG Working Group on lower limits of energy and protein and upper limits of protein intakes. International Dietary Energy Consultative Group.
Durnin J.V., Garlick P., Jackson A.A., Schürch B., Shetty P.S., Waterlow J.C., 1999. European Journal of Clinical Nutrition, 53 (Suppl. 1) pp. S174-S176.
 
The predictive value of plantar flexion of the toes in the assessment of neuropathic voiding disorders in patients with spine lesions at the thoracolumbar level.
Schurch B., 1999. Archives of Physical Medicine and Rehabilitation, 80 (6) pp. 681-686.
 
Botulinum A toxin in spinal cord injury.
Schurch B., 1998. Archives of Physical Medicine and Rehabilitation, 79 (11) p. 1481.
 
Does sacral posterior rhizotomy suppress autonomic hyper-reflexia in patients with spinal cord injury?
Schurch B., Knapp P.A., Jeanmonod D., Rodic B., Rossier A.B., 1998. British Journal of Urology, 81 (1) pp. 73-82.
 
Report of the IDECG/IUNS Working Group on IUGR effects on neurological, sensory, cognitive, and behavioral function.
Goldenberg R., Hack M., Grantham-McGregor B., Schürch B., 1998. European Journal of Clinical Nutrition, 52 (Suppl. 1) pp. S100-S101.
 
The 'Dejerines': an historical review and homage to two pioneers in the field of neurology and their contribution to the understanding of spinal cord pathology.
Schurch B., Dollfus P., 1998. Spinal Cord, 36 (2) pp. 78-86.
 
Assessment of autonomic dysreflexia in patients with spinal cord injury.
Curt A., Nitsche B., Rodic B., Schurch B., Dietz V., 1997. Journal of Neurology, Neurosurgery, and Psychiatry, 62 (5) pp. 473-477.
 
Autonomic hyperreflexia revisited.
Schurch B., Knapp P.A., Rossier A.B., 1997. Urologia Internationalis, 58 (3) pp. 148-152.
 
Botulinum A toxin as a treatment of detrusor-sphincter dyssynergia in patients with spinal cord injury: MRI controlled transperineal injections.
Schurch B., Hodler J., Rodic B., 1997. Journal of Neurology, Neurosurgery, and Psychiatry, 63 (4) pp. 474-476.
 
Posterior sacral rhizotomy and intradural anterior sacral root stimulation for treatment of the spastic bladder in spinal cord injured patients.
Schurch B., Rodic B., Jeanmonod D., 1997. Journal of Urology, 157 (2) pp. 610-614.
 
Prostaglandin E2 measurements: their value in the early diagnosis of heterotopic ossification in spinal cord injury patients.
Schurch B., Capaul M., Vallotton M.B., Rossier A.B., 1997. Archives of Physical Medicine and Rehabilitation, 78 (7) pp. 687-691.
 
Recovery of bladder function in patients with acute spinal cord injury: significance of ASIA scores and somatosensory evoked potentials.
Curt A., Rodic B., Schurch B., Dietz V., 1997. Spinal Cord, 35 (6) pp. 368-373.
 
The value of sympathetic skin response recordings in the assessment of the vesicourethral autonomic nervous dysfunction in spinal cord injured patients.
Schurch B., Curt A., Rossier A.B., 1997. Journal of Urology, 157 (6) pp. 2230-2233.
 
Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients.
Schurch B., Hauri D., Rodic B., Curt A., Meyer M., Rossier A.B., 1996. Journal of Urology, 155 (3) pp. 1023-1029.
 
Post-traumatic syringomyelia (cystic myelopathy): a prospective study of 449 patients with spinal cord injury.
Schurch B., Wichmann W., Rossier A.B., 1996. Journal of Neurology, Neurosurgery, and Psychiatry, 60 (1) pp. 61-67.
 
Report of the working group on general principles of assessing energy requirements.
Buyckx M., Dupont J.L., Durnin J.V., Ferro-Luzzi A., Roberts S.B., Schürch B., Shetty P.S., 1996. European Journal of Clinical Nutrition, 50 (Suppl. 1) pp. S186-S187.
 
Report on the working group on energy requirements of older individuals.
Dupont J.L., Durnin J.V., Ferro-Luzzi A., Roberts S.B., Schürch B., Shetty P.S., 1996. European Journal of Clinical Nutrition, 50 (Suppl. 1) pp. S192.
 
Malnutrition and behavioral development: the nutrition variable.
Schürch B., 1995. Journal of Nutrition, 125 (8 Suppl) pp. 2255S-2262S.
 
Analyses of 94 consecutive spinal cord injury patients using ASIA definition and modified Frankel score classification.
Capaul M., Zollinger H., Satz N., Dietz V., Lehmann D., Schurch B., 1994. Paraplegia, 32 (9) pp. 583-587.
 
Dekubitus [Decubitus ulcer].
Schurch B., 1994. Deutsche Medizinische Wochenschrift, 119 (13) p. 485.
 
Detrusor bladder neck dyssynergia revisited.
Schurch B., Yasuda K., Rossier A.B., 1994. Journal of Urology, 152 (6 Pt 1) pp. 2066-2070.
 
Errors and limitations of the multimodality checking methods of defective spinal intrathecal pump systems. Case report.
Schurch B., 1993. Paraplegia, 31 (9) pp. 611-615.
 
Rehabilitation bei Querschnittgelähmten [Rehabilitation of paraplegic patients].
Kuhn W., Waldis M., Schurch B., 1991. Schweizerische Rundschau für Medizin Praxis = Revue Suisse de Médecine Praxis, 80 (41) pp. 1096-1108.
 
Dysfonctions érectiles du blessé médullaire masculin [Erectile dysfunction of male spinal cord injury patients].
Schurch B., Kuhn W., 1990. Schweizerische Rundschau für Medizin Praxis = Revue Suisse de Médecine Praxis, 79 (38) pp. 1085-1088.
 
Effets de la Toxine Botulinique A sur le sphincter strié périurétral des vessies neurogènes. Etude préliminaire [Effects of Botulinum A Toxin on the periurethral striated sphincter of the neurogenic bladder. Preliminary study].
Schurch B., Hauri D., Largo M., Kreienbühl B., Meyer E., Rossier A.B., 1990. Journal d'Urologie, 96 (7) pp. 375-380.
 
Intérêt de la rééducation dans l'incontinence urinaire féminine [The value of retraining in female urinary incontinence].
Schurch B., Van Orle M.A., 1988. Therapeutische Umschau. Revue Thérapeutique, 45 (7) pp. 474-483.
 
Le traitement par agents physiques des arthroses [The treatment of arthroses using physical agents].
Walther C., Schurch B., 1988. Therapeutische Umschau. Revue Thérapeutique, 45 (7) pp. 490-494.
 
Fractures of the radial head and lesions of the lower radius and ulna in the adult: the importance of the prosthesis in resection.
Nonnenmacher J., Schurch B., 1987. Annales de Chirurgie de la Main, 6 (2) pp. 123-130.
 
In vivo behaviour of gamma globulin preparations.
Morell A., Schürch B., Ryser D., Hofer F., Skvaril F., Barandun S., 1980. Vox Sanguinis, 38 (5) pp. 272-283.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University